Nelli Bejanyan, MD

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation

Nelli Bejanyan

Contact Info

Mailing Address:
Division of Hematology, Oncology and Transplantation
420 Delaware Street SE, MMC 480
Minneapolis, MN 55455

Administrative Assistant Name
Kristin Blomquist

Administrative Phone

Administrative Email

Administrative Fax Number

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation

Hematologist / Oncologist

Medical School, Yerevan State Medical University, Yerevan, Armenia

Internal Medicine Residency, Cleveland Clinic, Cleveland, OH

Residency, Worchester Medical Center, Worchester, MA

Bone Marrow Failure Disorders; Hematology and Medical Oncology Fellowship, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH


Dr. Bejanyan completed Internal Medicine residency training at the Cleveland Clinic Ohio in 2008. She subsequently completed a clinical and research fellowship in Bone Marrow Failure Disorders in 2009 followed by fellowship training in Hematology and Medical Oncology from the Cleveland Clinic in 2012.

Awards & Recognition

  • Summa Cum Laude/Golden Medal, Yerevan State Medical University
  • Mkhitar Heratsi Award: “Best Medical Student, Class of 1993,” Armenia

Professional Associations

  • Member, American Medical Association (2007-present)
  • Associate Member, American Society of Bone Marrow Transplantation (2011-present)
  • Associate Member, American Society of Hematology (2010-present)
  • Associate Member, American Society of Clinical Oncology (2010-present)



  • Bejanyan N, Rogosheske J, Defor T, Lazaryan A, Esbaum K, Holtan S, Arora M, MacMillan M, Weisdorf D, Jacobson P, Wagner J and Brunstein C. Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-Versus-Host Disease in Reduced Intensity Conditioning Double Umbilical Cord Blood Transplantation. (Manuscript accepted for publication, Biol Blood Marrow Transplant 2015; Reference: YBBMT53771)
  • Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, Blazar BR, MacMillan ML, Weisdorf DJ. Composite endpoint of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood. 2015 Jan 15. pii: blood-2014-10-609032. [Epub ahead of print]
  • Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, deLima M, Bunjes DW, Zhang MG. “Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.” Biol Blood Marrow Transplant. 2014 Nov 15. Pii:S1083-8791(14)00679-X. [Epub ahead of print] PMID: 25460355
  • Warlick ED, Peffault de Latour R, Shanley R, Robin M, Bejanyan N, Xhaard A, Brunstein CG, Sicre de Fontbrune F, Ustun C, Weisdorf DJ, Socie G. “Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia: Similar Outcomes Regardless of Donor Type.” Biol Blood Marrow Transplant. 2014 Nov 6. Pii:S1083-8791(14)00669-7 [Epub ahead of print] PMID: 25452032
  • Bejanyan N, Oran B, Shanley R, Warlick E, Ustun C, Vercellotti G, Verneris M, Wagner JE, Weisdorf D, Brunstein C. Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation. Bone Marrow Transplant. 2014 Aug;49(8):1029-35.



Blood and Marrow Transplant (BMT) Clinic;Masonic Cancer Center

Board Certifications

Internal Medicine; Hematology; Medical Oncology

Clinical Interests

Malignant Hematology; Bone Marrow Transplantation